Scientists hunt for genetic clues to Menière's disease

NCT ID NCT07518069

Recruiting now Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to uncover genetic and biological differences between people with Menière's disease, those with vestibular migraine, and healthy individuals. Researchers will analyze blood samples from 250 participants to look for specific gene variations and biohumoral factors. The goal is to better understand what causes these conditions and how they differ.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help identify genetic markers or biological factors that distinguish Menière's disease from vestibular migraine, potentially guiding future diagnostic or treatment approaches.
What could go wrong: This is an observational study, not a treatment trial. It is exploratory and may not lead to immediate clinical changes. Results may not apply to non-Caucasian populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENIERE'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Meniere disease migraine with brainstem aura Vertigo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENIERE'S DISEASE VERTIGO VESTIBULAR MIGRAINE

Contacts and locations

Locations

IRCCS San Raffaele
RECRUITING

Milan, Italy, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.